IL18 and Hyperglycemia: Its activation by hyperglycemia, saturated fatty acids, ceramides, and other endogenous danger signals leads to the secretion of IL-1β and IL-18, promoting insulin resistance, endothelial dysfunction, and atherosclerotic progression.